SWOG clinical trial number
SWOG-7719
Addition of DDP and Bleomycin to VBAP in Relapsing and Resistant Myeloma Patients
Closed
Abbreviated Title
Addition of DDP and Bleomycin to VBAP in Relapsing and Resistant Myeloma Patients
Activated
08/12/1977
Closed
10/17/1979
Publication Information Expand/Collapse
1984
Addition of Cisplatin and Bleomycin to Vincristine- Carmustine-Doxorubicin-Prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: A Southwest Oncology Group study.
1979
Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.
Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.
Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.
Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.
Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.